Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Heike Zeitler"'
Autor:
J. Nadal, N. Marquardt, G. Goldmann, J. Oldenburg, Claudia Klein, S. Horneff, Heike Zeitler, G. Di Prinzio
Publikováno v:
Science meets clinical practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dcc786458963b7efabce152c916e129
https://doi.org/10.1055/s-0039-1680179
https://doi.org/10.1055/s-0039-1680179
Autor:
Heike Zeitler, J. Oldenburg, N. Marquardt, Claudia Klein, J. Nadal, G. Goldmann, G. Di Prinzio, S. Horneff
Publikováno v:
Science meets clinical practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6aa79ca8b9c018f38a87d6a3bd3bb99e
https://doi.org/10.1055/s-0039-1680124
https://doi.org/10.1055/s-0039-1680124
Autor:
G. Goldmann, Claudia Klein, S. Horneff, J. Nadal, J. Oldenburg, N. Marquardt, Heike Zeitler, G. Di Prinzio
Publikováno v:
Science meets clinical practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df36b5f6c765461e58a7db8991cc241e
https://doi.org/10.1055/s-0039-1680167
https://doi.org/10.1055/s-0039-1680167
Autor:
Heike Zeitler, Stefan Schlabe, Anna-Maria Eis-Hübinger, Ulrich Spengler, Johannes Oldenburg, Georg Goldmann, Kathrin van Bremen
Publikováno v:
Haemophilia. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0a860783044aa936099dbe55e797b5a
https://doi.org/10.1111/hae.13688
https://doi.org/10.1111/hae.13688
Autor:
G. Goldmann, Johannes Oldenburg, Heike Zeitler, Gudrun Ulrich-Merzenich, Annekristin Hausen, Anna Pavlova
Publikováno v:
Thrombosis research. 179
The administration of FVIII leads to inhibitors in up to 30% of patients with hemophilia A (HA), the most severe treatment complication. FVIII-mannosylation fosters the presentation of FVIII to CD4Investigation of the association between the inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed6093eeceb27d68498550bb46f4a39
https://pubmed.ncbi.nlm.nih.gov/31141731
https://pubmed.ncbi.nlm.nih.gov/31141731
Publikováno v:
Atherosclerosis Supplements. 18:74-79
In Acquired Haemophilia (AH) autoantibodies against blood coagulation factors, mainly FVIII, inhibit the blood coagulation cascade. The clinical symptoms can vary from minor to severe life threatening bleedings. At present it is unclear if the intens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c62be3bf2a1f67741753b395237b7ee
https://doi.org/10.1016/j.atherosclerosissup.2015.02.015
https://doi.org/10.1016/j.atherosclerosissup.2015.02.015
Publikováno v:
Therapeutic Apheresis and Dialysis. 19:405-410
Plasmapheresis is a well-accepted treatment option in severe hypertriglyceridemia-induced pancreatitis (HTGP). The rationale behind this approach is the depletion of triglycerides and the reduction of inflammatory cytokines. The time span between ons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdaf8efae939d108cd66b694f5c3cc8c
https://doi.org/10.1111/1744-9987.12286
https://doi.org/10.1111/1744-9987.12286
Autor:
Gudrun Ulrich-Merzenich, Anna Koptina, Heike Zeitler, J Müller, Olaf Kelber, Frederik Hartbrod
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 34
Background Cytokines and chemokines (CC) play a central role in immunoregulatory and inflammatory processes. Neutralising antibodies for single proinflammatory cytokines have developed into a powerful, though expensive and not always curative therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::816f8849d091e607e815d9ae9f27dbf0
https://pubmed.ncbi.nlm.nih.gov/28899503
https://pubmed.ncbi.nlm.nih.gov/28899503
Autor:
Johannes Oldenburg, Gudrun Ulrich-Merzenich, Heike Zeitler, Natascha Marquardt, Georg Goldmann
Publikováno v:
Therapeutic Apheresis and Dialysis. 18:103-110
Postpartum hemorrhage is a common cause of maternal mortality. Acquired hemophilia (AH) is a rare, life-threatening bleeding disorder induced by autoantibodies against coagulation factors (inhibitors). We report about eight patients with postpartum A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b363d55418cabe80d85136b28e44b48f
https://doi.org/10.1111/1744-9987.12061
https://doi.org/10.1111/1744-9987.12061
Autor:
Gudrun Ulrich-Merzenich, Heike Zeitler
Publikováno v:
Expert Opinion on Therapeutic Targets. 17:905-919
The lectin-like oxidized LDL receptor-1 (LOX-1) is a scavenger receptor and is regarded as a central element in the initiation of endothelial dysfunction and its further progression to atherosclerosis. Increasing numbers of studies suggest that thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431d46f71cb350c16ba368591fba7fb0
https://doi.org/10.1517/14728222.2013.805748
https://doi.org/10.1517/14728222.2013.805748